X
Subscription
Thank You
Thank you for your subscription
* Required fields
Life Sciences & Med Tech
company
contacts
sector
status
description

CEO: Nuno Arantes-Oliveira

nao@alfama.com.pt

sector:

Biotechnology

status:
Growth
description:

Alfama is a world-leader in the development of carbon monoxide-releasing molecules (CO-RMs) as pharmaceutical agents, controlling most of the relevant IP in the field. Alfama's first clinical candidate will become the standard-of-care for liver injury: in addition Alfama controls a collection of about 1,000 CO_RMs, many of which have shown efficacy in a wide range of diseases and conditions.

CEO: Laura Cerqueira

lauracerqueira@biomode-sa.com

sector:

Biotechnology

status:
Exited
description:

Biomode's kits detect specific micro-organisms within hours, providing an analysis regarding the organism's resistance to antibiotics. The technology prevents prolonged and erroneous treatments, false negatives and side effects detrimental to patients.

CEO: João Fonseca

joaogfonseca@biosurfit.com

sector:

Medical Devices

status:
Growth
description:

Company of development and production of innovation technologies for the market of patient-based diagnostic tests (Point-of-Care). The spinit® solution is the first and only one to allow one blood drop analysis, presenting results of parameters of different diagnostic specialties (hematology, immunoassay and clinical chemistry) in less than 5 minutes using always the same equipment of reading.

CEO: Bruno Sommer Ferreira

bsf@biotrend.biz

sector:

Biotechnology

status:
Early
description:

Provides advanced services for the development, optimisation, intensification and scale-up of industrial biotechnology processes.

CEO: Rui Brito

rui.brito@bsimsquare.com

 

sector:

Biotechnology

status:
Seed
description:

BSIM2 develops technology for the development of medication used to fight neurodegenerative amyloid diseases.

sector:

Healthcare IT

status:
Seed
description:
Coimbra Genomics has developed ELSIE - the first clinical decision support platform that allows any physician to use the genetic information of his patients allowing a more personalized diagnosis. ELSIE is a simple, highly scalable and completely safe solution for physicians to enter the world of personalized medicine.
sector:

Obesity

status:
Early
description:

Developing genomic platforms for the reserach of gene phenotypes in fruit flies for translation to human treatment. Special focus on obesity.

CEO: Teresa Alves

teresa.alves@genibet.com

sector:

Biotechnology

status:
Growth
description:

Providing biopharmaceutical CMO services (Contract Manufacturing Organisation).

CEO: João Guedes

joao.guedes@im3dical.com

sector:

Healthcare IT

status:
Exited
description:

Providing software solutions to support, manage and optimise the entire clinical and administrative flow involved in clinical diagnostic imaging. The SAAS, cloud-based platform offers a single solution connecting clinical reports (RIS) and image reviewing (PACS) anywhere, anytime.

sector:

Biotechnology

status:
Seed
description:

Immunethep is a biotechnology company that is a Spin-off from the University of Oporto focused on drug development for Immune System related pathologies.